Artificial intelligence (AI)–generated content on glucagon-like peptide-1 receptor agonists (GLP-1RAs) gave informationally detailed responses, but its readability remains suboptimal for many patients.
Artificial intelligence (AI)–generated content on glucagon-like peptide-1 receptor agonists (GLP-1RAs) gave informationally detailed responses, but its readability remains suboptimal for many patients.